Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30013 | 176 | 36.7 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
3175 | 2 | ID 1//NRSF//ID1 | 2160 |
30013 | 1 | ENDOCRINE SURG S//HASH1//CLIN SCI H4 750 | 176 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ENDOCRINE SURG S | address | 3007264 | 15% | 67% | 26 |
2 | HASH1 | authKW | 1009433 | 5% | 73% | 8 |
3 | CLIN SCI H4 750 | address | 861488 | 7% | 41% | 12 |
4 | ACHAETE SCUTE HOMOLOG 1 | authKW | 780734 | 3% | 75% | 6 |
5 | ACHAETE SCUTE COMPLEX LIKE 1 | authKW | 722903 | 3% | 83% | 5 |
6 | CHILDRENS HOSP CHILDREN | address | 520491 | 2% | 100% | 3 |
7 | HAIRY ENHANCER OF SPLIT 1 | authKW | 520491 | 2% | 100% | 3 |
8 | INSM1 | authKW | 500071 | 4% | 41% | 7 |
9 | INSULINOMA ASSOCIATED 1 | authKW | 462656 | 2% | 67% | 4 |
10 | SUBEROYL BIS HYDROXAMIC ACID | authKW | 390367 | 2% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1047 | 40% | 0% | 71 |
2 | Surgery | 156 | 18% | 0% | 31 |
3 | Pathology | 139 | 9% | 0% | 15 |
4 | Developmental Biology | 124 | 6% | 0% | 10 |
5 | Cell Biology | 105 | 14% | 0% | 25 |
6 | Genetics & Heredity | 71 | 10% | 0% | 17 |
7 | Medicine, Research & Experimental | 50 | 7% | 0% | 13 |
8 | Biotechnology & Applied Microbiology | 28 | 7% | 0% | 12 |
9 | Biochemistry & Molecular Biology | 24 | 14% | 0% | 25 |
10 | Respiratory System | 20 | 3% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCRINE SURG S | 3007264 | 15% | 67% | 26 |
2 | CLIN SCI H4 750 | 861488 | 7% | 41% | 12 |
3 | CHILDRENS HOSP CHILDREN | 520491 | 2% | 100% | 3 |
4 | CANC HOSP THYROID NECK TUMOR | 173497 | 1% | 100% | 1 |
5 | CARBONE CANC WISCONSIN MED 3028 | 173497 | 1% | 100% | 1 |
6 | CLIN SCI H4750 | 173497 | 1% | 100% | 1 |
7 | CLIN SCI K4 623 | 173497 | 1% | 100% | 1 |
8 | CLIN SCI K4623 | 173497 | 1% | 100% | 1 |
9 | DWAN VARIETY CLUB CARDIO VASC | 173497 | 1% | 100% | 1 |
10 | ENDOCRINE SURG SSECT ENDOCRINE SURG | 173497 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER GENE THERAPY | 3181 | 3% | 0% | 6 |
2 | GENE EXPRESSION PATTERNS | 1563 | 2% | 0% | 3 |
3 | SURGERY | 1407 | 5% | 0% | 9 |
4 | MOLECULAR CANCER THERAPEUTICS | 1060 | 3% | 0% | 5 |
5 | ANNALS OF SURGICAL ONCOLOGY | 871 | 3% | 0% | 6 |
6 | ONCOLOGIST | 702 | 2% | 0% | 3 |
7 | RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY | 665 | 1% | 0% | 1 |
8 | AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 634 | 1% | 0% | 2 |
9 | JOURNAL OF SURGICAL RESEARCH | 591 | 3% | 0% | 6 |
10 | KEIO UNIVERSITY SYMPOSIA FOR LIFE SCIENCE AND MEDICINE | 567 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JASKULA-SZTUL, R , PISARNTURAKIT, P , LANDOWSKI, M , CHEN, H , KUNNIMALAIYAAN, M , (2011) EXPRESSION OF THE ACTIVE NOTCH1 DECREASES MTC TUMOR GROWTH IN VIVO.JOURNAL OF SURGICAL RESEARCH. VOL. 171. ISSUE 1. P. 23-27 | 15 | 63% | 6 |
2 | ADLER, JT , HOTTINGER, DG , KUNNIMALAIYAAN, M , CHEN, H , (2010) INHIBITION OF GROWTH IN MEDULLARY THYROID CANCER CELLS WITH HISTONE DEACETYLASE INHIBITORS AND LITHIUM CHLORIDE.JOURNAL OF SURGICAL RESEARCH. VOL. 159. ISSUE 2. P. 640-644 | 13 | 68% | 16 |
3 | ADLER, JT , HOTTINGER, DG , KUNNIMALAIYAAN, M , CHEN, H , (2008) HISTONE DEACETYLASE INHIBITORS UPREGULATE NOTCH-1 AND INHIBIT GROWTH IN PHEOCHROMOCYTOMA CELLS.SURGERY. VOL. 144. ISSUE 6. P. 956-961 | 13 | 65% | 18 |
4 | ZAREBCZAN, B , CHEN, H , (2010) SIGNALING MECHANISMS IN NEUROENDOCRINE TUMORS AS TARGETS FOR THERAPY.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 39. ISSUE 4. P. 801-+ | 21 | 40% | 2 |
5 | SIPPEL, RS , CARPENTER, JE , KUNNIMALAIYAAN, M , CHEN, H , (2003) THE ROLE OF HUMAN ACHAETE-SCUTE HOMOLOG-1 IN MEDULLARY THYROID CANCER CELLS.SURGERY. VOL. 134. ISSUE 6. P. 866-871 | 11 | 85% | 40 |
6 | SOMNAY, YR , DULL, BZ , EIDE, J , JASKULA-SZTUL, R , CHEN, H , (2015) CHRYSIN SUPPRESSES ACHAETE-SCUTE COMPLEX-LIKE 1 AND ALTERS THE NEUROENDOCRINE PHENOTYPE OF CARCINOIDS.CANCER GENE THERAPY. VOL. 22. ISSUE 10. P. 496 -505 | 22 | 32% | 1 |
7 | ADLER, JT , HOTTINGER, DG , KUNNIMALAIYAAN, M , CHEN, H , (2009) COMBINATION THERAPY WITH HISTONE DEACETYLASE INHIBITORS AND LITHIUM CHLORIDE: A NOVEL TREATMENT FOR CARCINOID TUMORS.ANNALS OF SURGICAL ONCOLOGY. VOL. 16. ISSUE 2. P. 481 -486 | 12 | 60% | 13 |
8 | KUNNIMALAIYAAN, M , NDIAYE, M , CHEN, H , (2007) NEUROENDOCRINE TUMOR CELL GROWTH INHIBITION BY ZM336372 THROUGH ALTERATIONS IN MULTIPLE SIGNALING PATHWAYS.SURGERY. VOL. 142. ISSUE 6. P. 959-964 | 10 | 77% | 3 |
9 | KUNNIMALAIYAAN, M , CHEN, H , (2007) TUMOR SUPPRESSOR ROLE OF NOTCH-1 SIGNALING IN NEUROENDOCRINE TUMORS.ONCOLOGIST. VOL. 12. ISSUE 5. P. 535-542 | 20 | 32% | 61 |
10 | VACCARO, A , CHEN, H , KUNNIMALAIYAAN, M , (2006) IN-VIVO ACTIVATION OF RAF-1 INHIBITS TUMOR GROWTH AND DEVELOPMENT IN A XENOGRAFT MODEL OF HUMAN MEDULLARY THYROID CANCER.ANTI-CANCER DRUGS. VOL. 17. ISSUE 7. P. 849-853 | 11 | 65% | 8 |
Classes with closest relation at Level 1 |